Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

US' CDC To Study Possible Link Between Heart Inflammation And Pfizer/BioNTech, Moderna Vaccines

06/23/2021 | 11:49am EDT


© MT Newswires 2021
All news about BIONTECH SE
08/05S&P 500, Nasdaq Reach Record Highs as Weekly Jobless Claims Decline, Trade De..
MT
08/05CLOSE UPDATE : S&P 500, Nasdaq Reach Record Highs as Weekly Jobless Claims Decli..
MT
08/05NOVAVAX : again delays seeking U.S. approval for COVID-19 vaccine
RE
08/05Equities Rise Midday With Oil as Weekly Jobless Claims Decline
MT
08/05MODERNA : says its COVID-19 shot maintains high efficacy through 6 months
RE
08/05Moderna says vaccine is 93% effective six months later
RE
08/05BIONTECH : Completes Acquisition of Kite's Neoantigen TCR Cell Therapy R&D Platf..
AQ
08/05European ADRs Move Higher in Thursday Trading
MT
08/05PFIZER : to Require COVID-19 Shots or Regular Testing for US Workers
MT
08/04BIONTECH : Completes Acquisition of Gilead Subsidiary's Neoantigen TCR Cell Ther..
MT
More news
Financials
Sales 2021 13 071 M 15 455 M 15 455 M
Net income 2021 7 590 M 8 974 M 8 974 M
Net cash 2021 8 581 M 10 146 M 10 146 M
P/E ratio 2021 11,3x
Yield 2021 -
Capitalization 82 654 M 97 797 M 97 729 M
EV / Sales 2021 5,67x
EV / Sales 2022 5,77x
Nbr of Employees 2 200
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 342,22 €
Average target price 165,41 €
Spread / Average Target -51,7%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE396.71%97 797
GILEAD SCIENCES, INC.18.85%86 839
WUXI APPTEC CO., LTD.43.36%72 049
REGENERON PHARMACEUTICALS20.25%60 161
VERTEX PHARMACEUTICALS-14.11%51 779
BEIGENE, LTD.32.78%31 922